Foreign Correspondent Podcast | Inside Belgium’s FDI Screening: Policy, Practice and Geopolitics
Starting 1 January 2026, the Belgian Federal Agency for Medicines and Health Products (“AFMPS”) will implement accelerated evaluation timelines for initial applications for clinical trials involving medicines for human use....more
We continue to see increased investigation and prosecution of corruption, fraud, modern slavery and workplace misconduct, especially in the construction, transportation and financial sectors. Investigations are boosted by...more